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Yersinia pestis, a Gram-negative bacterium that causes
bubonic and pneumonic plague, is able to rapidly disseminate to
other parts of its mammalian hosts. Y. pestis expresses plasmin-
ogen activator (PLA) on its surface, which has been suggested to
play a role in bacterial dissemination. It has been speculated that
Y. pestis hijacks antigen-presenting cells, such as macrophages
(Ms) and dendritic cells, to be delivered to lymph nodes to
initiate dissemination and infection. Both alveolar Ms and
pulmonary dendritic cells express a C-type lectin receptor,
DEC-205 (CD205), which mediates antigen uptake and presen-
tation. However, no ligand has been identified for DEC-205. In
this study, we show that the invasion of alveolarMs byY. pestis
depends both in vitro and in vivo on the expression of PLA.
DEC-205-expressing Ms and transfectants, but not their neg-
ative counterparts, phagocytosed PLA-expressing Y. pestis and
Escherichia coli K12 more efficiently than PLA-negative con-
trols. The interactions between PLA-expressing bacteria and
DEC-205-expressing transfectants or alveolar Ms could be
inhibited by an anti-DEC-205 antibody. Importantly, the block-
age of the PLA-DEC-205 interaction reduced the dissemination
ofY. pestis inmice. In conclusion,murineDEC-205 is a receptor
for PLA of Y. pestis, and this host-pathogen interaction appears
to play a key role in promoting bacterial dissemination.
Yersinia pestis is the Gram-negative bacterium that causes
bubonic and pneumonic plague. Y. pestis has evolved directly
from Yersinia pseudotuberculosis within the last 10,000–
20,000 years (1, 2). The Yersinia genus is composed of 12 spe-
cies, and 3 species of Yersinia are pathogenic to humans (3, 4).
Y. pseudotuberculosis and Yersinia enterocolitica cause mild
enteric diseases, whereas the hallmark of Y. pestis is its rapid
dissemination in the mammalian host resulting in bubonic and
pneumonic plague and high mortality.
All three pathogenic Yersinia share a virulence plasmid,
pCD1 (pYV), which is essential for pathogenesis (5, 6). This
plasmid encodes a type III secretion system (7), YadA {an
adherence and virulence surface molecule, although yadA is a
pseudogene inY. pestis (8, 9)}, and a number of secreted effector
proteins that inhibit bacterial phagocytosis and specific innate
immune responses (10).
Y. pestis harbors two additional plasmids, pPCP1 (9.6 kb) and
pMT1 (pFra) (102 kb), which encode the plasminogen activator
(PLA)3 and the F1 protein, respectively. The products of these
genes are necessary for tissue invasion (11), capsule formation
(12), and infection of the plague flea vector (13, 14). Capsule
formation by Y. pestis has been proposed to confer anti-phago-
cytic capabilities (15, 16). PLA is an outer membrane protease
that also plays a role in bacterial attachment and invasion of one
eukaryotic epithelial cell line, but the invasive function does not
involve its proteolytic activity (17). Recent studies have further
confirmed the important roles of PLA in the progression of
bubonic and pneumonic plague, in which PLA contributes to
dissemination of Y. pestis, especially to bubonic plague (14, 18).
Lipopolysaccharide (LPS) of many Gram-negative bacterial
pathogensmediates toxicity and resistance to serum killing and
phagocytosis and generally consists of three structural regions
as follows: (i) the lipid A backbone, (ii) an oligosaccharide core
(core LPS), and (iii) O-antigen (19, 20). However, Y. pestis does
not produce an O-antigen (21, 22). The shortened LPS is also
referred to as lipo-oligosaccharide and is presumably exposed
to the external environment. In general, Gram-negative bacte-
ria are classified as smooth or rough based on the presence or
lack of the O-antigen, respectively. An interesting observation
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supports the idea that Yersinia spp. expressing O-antigen
blocks enzymatic activity of PLA (23). Therefore, it is also pos-
sible that expression of O-antigen in Y. pestis could physically
shield interactions between PLA and potential host receptors.
Antigen-presenting cells (APCs) such as macrophages
(Ms) play an essential role in the host defense against invading
pathogens and in the control and maintenance of innate and
adaptive immunity (24, 25). Innate immune functions are ini-
tially carried out by the ability of APCs to phagocytose and kill
invading pathogens or to deliver them to other types of host
immune cells for further elimination of the pathogens. APCs
expressmembers of the C-type lectin family. For example, alve-
olar Ms express a C-type lectin receptor, DEC-205 (CD205).
Although DEC-205 participates in an important role in the
antigen-presenting process (26, 27), no ligand for this receptor
has yet been identified.
Some pathogens may pirate innate immune receptors for
their dissemination. It has been speculated that after entering
the host via a bite from an infected flea (10), Y. pestis may use
innate immune receptors present on APCs to traffic to lymph
nodes where they encounter host lymphocytes (10). This
hypothesis is reminiscent of the mechanism HIV-1 uses to tar-
get APCs. HIV-1 may hijack another C-type lectin receptor,
DC-specific intercellular adhesion molecule-grabbing non-in-
tegrin (DC-SIGN, CD209), so as to be captured and trafficked
to target cells such as CD4 lymphocytes in lymph nodes (28–
30). Human DC-SIGN is also expressed by a certain class of
Ms (31), including human alveolar Ms.
Recently, we demonstrated that human DC-SIGN and
mouse SIGN-R1 can be used as receptors for the core LPS of Y.
pestis, promoting bacterial adherence and phagocytosis to
human DCs and murine Ms (20).4 Based on these studies, we
have hypothesized that after Y. pestis enters the lungs
through aspiration, it invades alveolar Ms via core LPS-
DC-SIGN-SIGN-R1 interaction (20).4 In this study, we
explored whether Y. pestis can exploit this interaction to be
disseminated to spleens in a mouse model. Unexpectedly, we
found that in fact PLA can also mediate the binding of Y.
pestiswith host DEC-205, and the interaction may play a role
in bacterial dissemination.
EXPERIMENTAL PROCEDURES
Bacterial Strains—Escherichia coli K12 strain CS180 con-
tains core LPS but lacks O-antigen (33). CS1861 is an isogenic
strain of CS180 harboring pSS37, a plasmid containing all the
genes necessary for the expression of the Shigella dysenteriae 1
O-antigen (33–35) (Table 1). E. coli strains were cultured on
Luria-Bertani medium (LB) supplemented with 1.5% agar at
37 °C overnight.
Y. pseudotuberculosis (Y1) is a serotype O:1a strain and lacks
the virulence plasmid (pYV) and does not express the Ail pro-
tein.5 The strain was obtained from the CDC and used as a
control strain for invasion (20, 36), because this bacterium
invades almost all epithelial cell lines via an invasin-integrin
interaction (37).
All strains of Y. pestis used in this study are derived from the
KIM strain (38). There are nine derivatives of Y. pestis used in
this study as follows. 1) KIM6 was derived from wild-type
KIM by curing the virulence plasmid (pCD1 or pYV). 2)
KIM10was derived fromKIM6 by curing the pPCP plasmid.
3) KIM6 is a derivative of KIM6 obtained after spontaneous
deletion of the pgm (pigmentation) locus (38). 4) KIM10 is a
derivative of KIM6 obtained after curing the pPCP plasmid
and deletion of the pgm locus. 5) KIM6-O is KIM6/
pAY100.1 that expresses the O-antigen of Y. enterocolitica
serotypeO:3 from theO-antigen gene cluster cloned in plasmid
pAY100.1 (39). 6) KIM10-PLA is the KIM10 containing a
plasmid that expresses the PLA. 7) KIM10-ail is the
KIM10, whose ail gene is deleted (40). 8) KIM6-pBR322 is
KIM6 that carries the pBR322 plasmid. 9) KIM10-pBR322 is
KIM10 that carries pBR322 (Table 1). Strains were cultured at
26 °C onGC-based plates (Difco) supplementedwith 1%hemo-
globin (U. S. Biochemical Corp.) (20).
Mice—BALB/CJ mice were bred at the University of Illinois
at Chicago-Rockford animal facilities and used in this study.
BALB/CJ mice were selected, because of the expression of
SIGN-R1 and DEC-205 in peritoneal Ms and alveolar Ms,
respectively, in these mice (41–43).
Biological Reagents—Anti-mouse DEC-205, anti-mouse
SIGN-R1, and anti-human DC-SIGN antibodies were pur-
chased from SeroTec (Raleigh, NC). YTH71.3, a rat antibody
that recognizes CEACAM1 (CD66a), CEACAM6 (CD66c), and
CEACAM3 (CD66d), was purchased from Roche Applied
Science.
Isolation of Mouse Peritoneal and Alveolar Macrophages—
After euthanizing a mouse, its intact abdomen was exposed,
cleaned with 70% ethanol, and opened. 5 ml of RPMI
medium was injected into the intraperitoneal cavity. The
mouse abdomen was gently massaged for 3 min, and then
the lavage fluid was collected. The suspension containing the
peritoneal Ms was seeded in flasks and placed in a CO2 incu-
bator for 2 h. The cell layers were washed three times to remove
nonadherent cells. Ms were removed from the plastic surface
by incubating with citrate saline and re-seeded for interaction
assays or stained with antibodies to check the expression level
of receptors.
AlveolarMs were obtained using the following procedures.
After euthanizing a mouse, its bronchial tract was opened, and
1ml of RPMImediumwas injected into the lungs via a tiny tube.
The mouse chest was gently massaged for 3 min, and then the
lavage fluid was collected. The purification processes followed
the same process as the peritoneal Ms.
Host Cell Lines—Mouse C-type lectin transfectants, CHO-
mDC-SIGN, CHO-mSIGN-R1, CHO-mSIGN-R3, and CHO-
mDEC-205 (CD205), were generated by transfecting CHOcells
with mouse corresponding C-type lectin cDNAs, followed by
selection for stable surface expression as originally described
(41). CHO-NEOwas used as a control cell line, which expresses
the neomycin resistance gene only.
Adherence and Phagocytosis Assays—The assays for adher-
ence and phagocytosis have been described previously (44, 45).
4 S. Zhang, C. G. Park, S. S. Bartra, A. Shetty, P. Zhang, G. Zheng, S. Bulgheresi,
Z. Yu,G. V. Plano, J. Klena,M. Skunilk, J. Hinnebusch, andT. Chen, submitted
for publication.
5 T. Chen, unpublished data.
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Briefly, host cells (CHO,HeLa, dendritic cells, ormacrophages)
were plated in 24- or 96-well plates. Cells were suspended in
RPMI medium with 2% FCS at a concentration of 4  105/ml.
One-half ml of each of these cell suspensions were added to
24-well plates, and after addition of 50 l of bacterial suspen-
sions at a concentration of 1  107 colony-forming units
(CFU)/ml, the cells were allowed to incubate for 2.5 h (2 h for
dendritic cells and alveolarMs) at 37 °C in the presence of 5%
CO2. The cell monolayers were then washed three times with
phosphate-buffered saline. The number of associated bacteria
(adherent and internalized) per cell was quantified by washing
the cells three times with RPMI medium containing 2% FCS
and plating the culture after the cells were lysed by the addition
of 0.5% saponin (Calbiochem).
To determine the internalization of bacteria, gentamicin,
which kills extracellular bacteria but cannot penetrate into host
cells, was added into each well to a final concentration of 100
g/ml, and the cultures were incubated for 60 min. Cells were
washed twice to remove the antibiotic. Then the cells were sus-
pended in phosphate-buffered saline containing 0.5% saponin,
diluted, and plated on LB as well as theY. pestis plates. The level
of internalization of bacteria in these host cells was calculated
by determining the CFU recovered from lysed cells. All exper-
iments were performed in triplicate, and each experiment was
repeated three times. The data were expressed as mean  S.E.
Statistical significance was calculated using the Student’s t test.
For the inhibition assay, anti-DEC-205 antibody was added
20 min prior to the addition of bacteria at a concentration of 5
g/ml. The concentration used was based on our preliminary
data and was selected based on the fact that at these concentra-
tions there was no influence on the survival of bacteria and host
cells, as previously and recently shown (19, 20, 46).
Determination of Phagocytosis by Flow Cytometry—The fol-
lowing method was used to supplement the survival-based
phagocytosis assay described above becauseAPCs are known to
kill some phagocytosed bacteria (20, 47). Briefly, bacteria were
suspended in RPMI medium containing 5- and 6-carboxyfluo-
rescein diacetate, succinimidyl ester (CFDA-S.E.; Molecular
Probes, Eugene, OR), for 40 min and washed twice with RPMI
medium to remove the excess dye. Labeled bacteria were added
to M cultures for 2 h. Cell cultures were washed twice to
remove unbound bacteria. Ms plus associated bacteria were
fixed with 2% paraformaldehyde. Before flow cytometry, a 1:10
dilution of trypan blue (0.4%, Sigma) was added to the fixed cell
cultures, and the mixture was incubated at ambient tempera-
ture for 10 min (47) to quench the fluorescence from extracel-
lular labeled bacteria. Trypan blue blocks fluorescence but can-
not penetrate host cells; therefore, fluorescence from
internalized bacteria was not influenced by addition of trypan
blue. The rate of bacterial internalization was determined by
comparing the intensity of fluorescence-positiveMswith var-
ious bacteria. The greater the fluorescence intensity, the more
bacteria are phagocytosed byMs. All of the results were eval-
uated in triplicate.
In Vivo Phagocytosis Assays—After anesthetizing amouse, its
bronchial tract was opened, and about 20 l of bacterial sus-
pension (A600  0.1) was injected deep into the lungs using a
tiny tube. After 2 h, mice were euthanized and alveolar Ms
were collected as described in the procedure for alveolar Ms
above. The numbers of cells in lavage fluid were counted for
each collection. 1 105 mouse cells were seeded into each well
of 96-well plates, containing RPMI medium with 2% FCS and
gentamicin at a concentration of 100 g/ml and were then
incubated for 1.5 h to allow theMs to adhere to plates and kill
the extracellular bacteria. Each well was washed three times
with RPMImediumcontaining 2%FCS to remove nonadherent
cells and lysed with saponin, following the same procedures as
used in the in vitro phagocytosis assays.
Dissemination Assay—In this study, the dissemination was
defined such that Y. pestis was transported from lungs to
spleens. In detail, mice were inoculated with Y. pestis KIM6-
pBR322, KIM6-O, KIM10-pBR322 and KIM10-PLA, at a
concentration of A600  1.5 in phosphate-buffered saline (0.2
ml) via the intranasal route with a small tube after anesthesia
(18, 48, 49).Mice were injected intravenously with ampicillin at
the same concentration in each of following days. After the 1st
day,micewere euthanized, and both the lungs and spleenswere
removed daily. Collected lungs and spleens were homogenized.
The homogenized tissueswere then lysedwith 1%TritonX-100
to release the bacteria 10min before they were plated onto agar
plates containing ampicillin. The total isolated CFU per spleen
was defined as the dissemination rate.
Three points should be noted. 1) 30 min before inoculation,
mice were injectedwith ampicillin at a final concentration of 50
g/g of mouse body weight to maintain the plasmid-based
expression of O-antigen in KIM6-O and PLA in KIM10-
PLA. The rationale for the high dose of bacteria (109/ml) in
the inoculum is discussed in depth under “Discussion.” 2) To
meet biosafety and regulatory requirements, the tetracycline
marker on the original pBR322has beendeleted. 3)TheY. pestis
strains used in this study were cultured at 26 °C; at this temper-
ature, Y. pestis does not produce the F1 capsule, which is capa-
ble of blocking interactions with host cells (15, 16, 20).
RESULTS
Y. pestis InvadesMouse AlveolarMacrophages—We recently
showed that humanDC-SIGNandmouse SIGN-R1 can be used
as receptors for the core LPS of Y. pestis, promoting bacterial
adherence and phagocytosis to human DCs and Ms, includ-
ing human alveolar Ms and murine peritoneal Ms (20).4
Therefore, we have speculated that Y. pestis might utilize the
interaction of core-LPS and SIGN-R1 to invademurine alveolar
Ms in the case of the mouse model. To investigate this
hypothesis, Y. pestis KIM6 (a natural rough strain with the
core LPS presumably exposed) and its isogenic derivative
KIM6-O (a smooth strain in which the outer core LPS is
shielded byO-antigen)were examined for their ability to invade
alveolar Ms. Two corresponding E. coli K12 strains CS180
(rough) and CS1861 (CS180 expressing an O-antigen, smooth)
were used as controls. We have used these sets of strains to
demonstrate that exposure of the core-LPS of E. coli and Y.
pestis is essential to initiate the interaction of core-LPS and
DC-SIGN/SIGN-R1 (19, 20, 47, 50)4 (Table 1). In addition,
mouse peritoneal Ms were used as control host cells that can
bindE. coli andY. pestis through the interaction of core LPS and
SIGN-R1.4 We reasoned that, like murine peritoneal Ms,
DEC-205 Is a Receptor for Y. pestis
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mouse alveolar Ms might use the samemechanism to phago-
cytose Y. pestis. The results presented in Fig. 1 show three phe-
nomena. 1) Y. pestis KIM6 invades alveolar and peritoneal
Ms equally well (Fig. 1A). 2) Phagocytosis of Y. pestis strain
KIM6-O by peritoneal and alveolar Ms was reduced com-
pared with Y. pestis strain KIM6 (Fig. 1, A and B), presumably
as a result of expression of O-antigen. 3) The most interesting
result was observed with our control infection using the E. coli
strains. Peritoneal Ms generated an effective phagocytic
response to E. coli K12 CS180 (rough), but not to CS1861 (with
expression of O-antigen), which was not the case when using
alveolar Ms. Both CS180 and CS1861 can only promote a
limited phagocytic response in alveolar Ms, indicating a clear
difference in the interaction of rough Gram-negative bacteria
with alveolar Ms and peritoneal Ms.
We have recently developed an in vivo phagocytosis assay
using peritoneal Ms,4 which lead us to examine the in vivo
phagocytosis of Y. pestis by alveolar Ms. The in vivo phagocy-
tosis of KIM6 and KIM6-O (Fig. 1C) shows a similar pat-
tern to the in vitro phagocytosis (Fig. 1A), although the num-
bers of recovered bacteria were much lower in vivo. We believe
that the low recovery of bacteria in vivo is because of the tech-
nical difficulty in achieving high concentrations of bacteria in
the lungs of livemice. It should be noted that the concentration
of inoculating bacteria was 100 times higher, in comparison
with in vitro invasion assay. For this experiment, we did not use
CS180/CS1861, because E. coli K12 are very sensitive to serum
killing. In short, the results indicate that the phagocytosis of Y.
pestis by alveolar Ms is involved with the molecule(s) other
than core LPS on Y. pestis.
DEC-205, Expressed on Mouse Alveolar Macrophages, Is a
Receptor for Y. pestis—The data presented in Fig. 1 indicate that
the invasion of alveolarMs by Y. pestismight not bemediated
by exposure of core LPS. This was initially surprising, as core
LPS is a ligand for the SIGN-R1 receptor, expressed on perito-
neal Ms.4 However, studies from several other investigators
have suggested that mouse alveolar Ms in fact do not express
SIGN-R1 (43) butmay express another receptor, DEC-205 (51).
To explain these contrasting experiments, we examined the
expression of DEC-205 and SIGN-R1 on alveolar and perito-
neal Ms. Our results confirm that mouse alveolar Ms and
peritoneal Ms predominantly express DEC-205 and SIGN-
R1, respectively (Fig. 2). However, in comparison with its CHO
transfectants (Fig. 3B), the expression of DEC-205 in nonacti-
vated alveolar Ms is moderate. Our data indicated that LPS-
activated alveolarMs did not enhance the expression ofDEC-
205 and their ability to phagocytose the Y. pestis (data not
shown).
Because alveolarMs do not express SIGN-R1,we examined
whether the invasion of Y. pestis into alveolarMs results from
the interaction between Y. pestis and DEC-205 (Fig. 2). Four
CHO transfectants stably expressing the mouse C-type lectin
receptors mDC-SIGN, mSIGN-R1, mSIGN-R3, and
mDEC-205 (CD205) (41, 42) were infected with Y. pestis
KIM6 and KIM6-O. CHO-NEO was used as a negative
control cell line. CS180 and Y. pseudotuberculosis (Y1) were
used as the positive control strains, because Y. pseudotubercu-
losis (Y1) grown at 26 °C invades most epithelial cell lines,
including CHO (36) via the invasin protein (52), and CS180was
shown to interact with mCHO-SIGN-R1 via its core LPS.4 In
addition, in comparison with other strains, only half the num-
bers of Y. pseudotuberculosis were loaded, because of its ability
to promote an aggressive invasion into epithelial cells. The
expression of each lectin on CHO cells is shown in Fig. 3B.4
Several phenomena can be observed from these results (Fig.
3A). Y. pestis KIM6 interacts with CHO-mDEC-205 but not
the CHO-NEO, showing that DEC-205 is a receptor for Y. pes-
tis. The interactions of CHO-mSIGN-R1 with Y. pestis KIM6
and CS180 are most likely because of the exposure of core LPS
on the bacteria as the isogenic derivative of both KIM6 and
CS180 expressing an O-antigen no longer effectively interact
with this transfectant, as also shown recently.4 We observed
that the expression of O-antigen on KIM6 was still able to
block the interaction of this Y. pestis with CHO-mDEC-205,
indicating that other potential ligands may also be shielded by
expression of O-antigen.
It should be noted that our preliminary data showed that
there is also a SIGN-R1- or DEC-205-independent interaction,
which can be inhibited by addition of heparin, a synthetic form
of heparan sulfate. We present this information, because hepa-
rin was included in the assays measuring bacteria-CHO-trans-
fectant interaction to reduce some non-DEC-205 or SIGN-R1-
specific interaction between Y. pestis and epithelial cells.4 The
rationale for the addition of heparin is addressed in detail under
“Discussion.”
Plasmid pPCP1 Is Involved in the Interaction of Y. pestis with
DEC-205 Receptor—As suggested above, core LPS, a ligand for
mouse SIGN-R1,4 may not participate in the interaction of
KIM6 Y. pestis with alveolar Ms, which express the DEC-
205. It should be recognized that Y. pestis KIM6 also contain
the pPCP1 plasmid as well as the pgm locus. This led us to
speculate that the ligands for the DEC-205 receptor might be
encoded either on the pPCP1 plasmid, which encodes nine
expressible genes, or the pgm locus containingmany important
genes that are related to pathogenesis of Y. pestis (53–55). Four
strains, KIM6, KIM6 (lacking the pgm locus), KIM10 (lack-
TABLE 1
Bacterial strains used in this study
Strains Genotypes phenotypes Refs.
E. coli K-12
CS180 Original type (rough) 33–35
CS1861 CS180 expressing O-antigen (smooth) 33–35
DH5 Original type (rough), similar to CS180 14
DH5-PLA DH5 expressing the PLA 14
Y. pestis
KIM6 The natural type (rough) 38
KIM10 KIM6 with pPCP1 plasmid cured 38
KIM6 KIM6 with deletion of pgm locus 38
KIM10 KIM6 with pPCP1 plasmid cured and
deletion of pgm locus
38
KIM6-O KIM6 expressing the O-antigen (smooth) 39
KIM10-PLA KIM10 expressing the PLA 14, 38
KIM10-ail KIM10 with deletion of ailC 40
KIM10-ail-PLA KIM10-ail expressing the PLA 14, 38, 40
KIM6-pBR322 KIM6 carrying pBR322 plasmid This study
KIM10-pBR322 KIM10 carrying pBR322 plasmid This study
Y. pseudotuberculosis
Y1, O:1Aa Wild-type expressing the invasin, but
with naturally pYV plasmid cured
and deletion of ail (smooth)
37
DEC-205 Is a Receptor for Y. pestis
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ing pPCP plasmid), and KIM10 (lacking both pgm locus and
pPCP plasmid), were examined for their ability to interact with
CHO-mDEC-205.Y. pseudotuberculosis (Y1)was used as a pos-
itive control. As shown in Fig. 4, Y. pestis KIM6 and KIM6
but not the KIM10 and KIM10
interact with CHO-DEC-205, indi-
cating that pPCP1 rather than the
pgm locus is necessary for the inter-
action with DEC-205. Again, hepa-
rin was present in this assay. Our
unpublished data5 further show that
KIM10 binds to CHO cells better
than KIM6 in the absence of hep-
arin, indicating that the presence of
the pPCP1 plasmid may inhibit
other adherence factors.
Plasminogen Activator of Y. pestis
Is a Ligand for DEC-205 and Plays a
Role in Interaction with Alveolar
Macrophages—Although the pPCP1
plasmid contains nine potential
expressiblegenes,PLAisthemoststud-
ied and notable component. In addi-
tion, work from other investigators
indicates that expression of O-antigen
in Yersinia spp. blocks the activity of
PLA encoded by the pPCP1 plasmid
(23). The data described in Fig. 3A also
show that expression of O-antigen
inhibits the interaction of Y. pestis
KIM6 containing pPCP1 with CHO-
mDEC-205. Therefore, KIM10-ail,
KIM10-ail-PLA (40), E. coli K12
DH5, and E. coli K12 DH5-PLA
were tested for their interactions with
CHO-mDEC-205 and alveolar Ms.
CHO-NEO was used as the negative
control.We find that removal of theail
gene reduces the non-C-type lectin-
mediated interaction5 as described and
discussed under “Experimental Proce-
dures” and “Discussion.” Fig. 5 shows
that KIM10-ail-PLA andE. coliK12
DH5-PLA, but not the KIM10-ail
and E. coli K12 DH5, interact with
CHO-DEC-205, demonstrating that
PLAofY.pestis is a ligand forDEC-205.
In addition, expression of PLA in
KIM10-ail andDH5 enhances the
ability to interact with alveolar Ms,
indicating that PLA participates in the
interaction of Y. pestis with alveolar
Ms.
Interactions of CHO-DEC-205
and Alveolar Macrophages with
PLA-expressing Y. pestis and E. coli
Is Inhibited by DEC-205 Antibody—
To verify the specificity of the Y.
pestis-alveolar M interaction, we examined whether the
interaction of PLA-expressingY. pestisKIM10-ail andE. coli
DH5 with CHO-DEC-205 and alveolar Ms could be inhib-
ited by anti-DEC-205 antibody. Anti-CD66 antibody was
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FIGURE1.PhagocytosisofY.pestisbymousealveolarmacrophagesoccurs invitroand invivo.Gentamicin
protection (A) and flow cytometry-based assays (B) were used to determine the invasion ability of Y. pestis
KIM6, KIM6-O, E. coli K12 CS180, and CS1681 (expression of O-antigen) into purified mouse alveolar Ms
and peritoneal Ms, and the latter is shown Footnote 5. The invasive nature of the E. coli strains with human
APCs has been described recently (19, 20, 47, 50). The in vivo phagocytosis of Y. pestis KIM6 and KIM6-O is
shown in C. *, p	 0.001, calculated by Student’s t test in the comparison of the invasion of alveolar Ms by Y.
pestis KIM6 to KIM6-O. **, p 	 0.005 in the in vivo comparison of invasion between these two strains.
Labeled and unlabeled bacteria are indicated by open and filled symbols, respectively (B). The greater the
fluorescence intensity, the more bacteria are phagocytosed by Ms.
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employed as a control antibody. Again, we usedY. pseudotuber-
culosis serotype O:1a grown at 26 °C, which mediates a DEC-
205-independent interaction, as a control strain. Fig. 6 shows
that anti-DEC-205 antibody blocks the invasion of the PLA-
KIM10-ail and -DH5 to CHO-DEC-205. Although this
antibody reduced the phagocytosis of PLA-KIM10-ail and
DH5 by alveolar Ms (Fig. 6A), the blockage was not com-
plete, indicating that other receptors on alveolarMs might be
involved in this interaction. Also,
the dynamic nature of APCs, which
presumably phagocytose most anti-
gens, could lead to specific or non-
specific phagocytosis. It should be
noted that the concentrations of
antibody used in this study did not
influence the viability of either bac-
teria or host cells (19) as also found
with our control strain Y. pseudotu-
berculosis (20). Together, these data
indicate that there is a specific inter-
action between DEC-205 of alveolar
Ms and PLA of Y. pestis.
Expression of PLA and O-antigen
Promotes and Inhibits Early Dis-
semination of Y. pestis, Respecti-
vely—PLA plays an important role
in promoting dissemination of Y.
pestis (14, 18). We have presented
data showing that DEC-205 is a
receptor for the PLA ligand. Expres-
sion of O-antigen by Y. pestis inhib-
its with the PLA-DEC-205 interac-
tion. The obvious question is
whether the PLA-DEC-205 interac-
tion enhances the dissemination of
Y. pestis and whether blockage of
this interaction would reduce the
dissemination. Therefore, Y. pestis
KIM6, KIM10, and KIM10-
PLA (PLA-expressing Y. pestis
KIM10) were examined for their
ability to translocate from lungs to
spleens. Briefly, mice were infected
with these strains via nasal inoculation to mimic pneumonic
plague (18, 48, 49). Then mice lungs and spleens were isolated,
homogenized, and spread onto Y. pestis plates. Our results (Fig.
7,A andB) show that both KIM6 and KIM10 could be trans-
mitted to spleens, but the KIM6 is more effective, as KIM10
was retained in the lung more. The most interesting result is
that the single gene-expressing KIM10-PLA partially regained
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FIGURE 3. Y. pestis but not E. coli K12 invades CHO-mDEC-205. A, invasion of E. coli K12 CS180, Y. pseudotu-
berculosis (Y1), and Y. pestis KIM6 and KIM6-O into CHO cell lines transfected by the mouse C-type lectins;
CHO-mDC-SIGN, CHO-mSIGN-R1, CHO-mSIGN-R3 and CHO-mDEC-205 (CD205) were quantified by incubating
the cell lines for 2.5 h with the bacterial strains and by killing the extracellular bacteria with 100 g/ml of
gentamicin. The number of phagocytosed bacteria was determined by counting CFU recovered following
gentamicin treatment. The expression levels of each transfectant are shown in B. C-type lectin and CHO-NEO
transfectants are shown in the open and filled curves, respectively. The level of expression for each receptor is
shown with fluorescence intensity. Based on the Student’s t test, *, p 	 0.001, comparing the interaction of
CHO-mDEC-205 with KIM6 to the interaction of CHO-NEO with the same bacterium.
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FIGURE 2. The expression of DEC-205 and SIGN-R1 in alveolar and peritoneal macrophages. Both alveolar and peritoneal Ms were examined for their
expression of DEC-205 and SIGN-R1 with flow cytometry. The level of expression for each receptor is shown with fluorescence intensity. The anti-human
DC-SIGN antibody was used as a negative control, which is shown as filled symbols.
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its ability to be transmitted to spleens, but this only occurred on
day 2. Furthermore, the retention rates in the lung for KIM10-
PLA were dramatically reduced after day 1. Finally, our data also
showthat bothKIM6 andKIM10 can persistently be dissem-
inated to spleens for up to 9 days although the isolation rates are
very low in the later stages (data not shown), indicating that the
nonvirulent Y. pestis can stay in the lungs for a reasonably long
period. However, if they are phagocytosed, these nonvirulent Y.
pestis can only live about 2–3 days. In short, the results suggest
that PLA plays a role in early Y. pestis dissemination during
pneumonic plague.
On the other hand, we also speculated that the PLA-DEC-
205 interactions, if blocked by expression of O-antigen, could
reduce the dissemination. To investigate this hypothesis,Y. pes-
tis KIM6 and its isogenic derivative KIM6-O were exam-
ined for their ability to disseminate tomouse spleens. Four days
after inoculation, the rate of dissemination was determined
using the same procedures shown in Fig. 7, A and B. A high
number of Y. pestis KIM6 (rough) but not KIM6-O
(smooth) were isolated from spleens (Fig. 7, C and D). In con-
trast, KIM6-O bacteria were retained in the lungs in much
higher numbers than KIM 6 bacteria. It is our presumption
that the reduction in dissemination of Y. pestis KIM6-O
might be due to its inability to interact with DEC-205.
Because expression of O-antigen inhibits dissemination and
the interaction between PLA and DEC-205, we suggest that the
PLA-promoted dissemination is based on the ability of PLA to
interact with DEC-205. Because KIM10 is still able to be dis-
seminated, other factors must also have participated in the Y.
pestis dissemination from lungs to spleens.
DISCUSSION
Y. pestis, the causative agent of pneumonic plague, is able to
rapidly disseminate from the lungs to other organs. Investiga-
tors have shown that PLA plays a crucial role in promoting Y.
pestis dissemination. It is speculated that Y. pestis hijacks APCs
to be delivered to lymph nodes, resulting in this dissemination.
In this study, we found that the PLA of Y. pestis is a ligand for
DEC-205. Our results also suggest that the PLA-DEC-205
interaction may mediate the dissemination of Y. pestis.
The DEC-205 receptor is expressed on many APCs in both
humans and mice (56, 57). The main function of DEC-205
receptor is related to antigen presentation (26, 27, 58). There-
fore, the DEC-205 molecule has been used to enhance host
responses for vaccine development against the HIV GAG pro-
tein and V-antigen from Y. pestis (59–61). On the other hand,
an important corollary to the ligand-receptor interaction is that
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some pathogens, including Y. pestis, have evolved mechanisms
of exploiting those very host defense molecules designed to
eliminate them, with the result of an expanded ability to dis-
seminate in the host, as explored in this study. However, there
are still several technical and scientific issues, which need to be
addressed to validate our findings and conclusions.
In this study, nine Y. pestis KIM variants were chosen for
investigating various aspects of the bacterial-host interaction,
including dissemination; however, none of the selected strains
were fully virulent (Table 1). This raises the issue of whether the
conclusions we have reached are significant in understanding
the pathogenic process of plague. Because of the virulent nature
of Y. pestis, this pathogen is considered a “select agent,” and its
use in experiments are tightly restricted by IRBs and federal
regulations; thus, it was not possible for us to use a virulent
strain in our experiments. However, over the entire course of
the dissemination experiments, the mouse fatality rate was
zero. In fact, we did not even observe that there were any symp-
toms of discomfort, such as fever among the inoculated mice,
suggesting that the innate immune system is very effective
against these invading pathogens. These observations clearly
confirm the reduced pathogenicity of these mutant strains.
Nevertheless, an advantage of using nonvirulent strains is
that they allow us to apply genetically defined mutants to
decode the complexity of host-pathogen interactions during Y.
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205 cells were also incubated with the KIM10-ail-PLA, E. coli K12 DH5-
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FIGURE 7. Expression of PLA and O-antigen enhances and reduces the
dissemination of Y. pestis, respectively. After nasal inoculation of KIM6,
KIM10 (lacking the pPCP plasmid), and KIM10-PLA, mice were euthanized.
Both lungs (A) and spleens (B) were separated, homogenized, and spread on
Y. pestis plates. The dissemination rate is the CFU recovered from whole
spleens or lungs. C and D, KIM6 and KIM6-O (expression of O-antigen)
were inoculated to mice following the same procedures as in A and B. The
data from day 4 were shown, and note the difference in scale between lungs
and spleens.
DEC-205 Is a Receptor for Y. pestis
31518 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 283•NUMBER 46•NOVEMBER 14, 2008
 at Y
O
N
SEI U
N
IV
ERSITY
 on O
ctober 29, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
pestis dissemination and infection. For example, we have used
nonvirulent strains to examine the role of specific ligand-recep-
tor pairs in the dissemination of Y. pestis tomouse spleens from
the lungs in experiments mimicking pneumonic plague. If a
virulent strain had been used, it would have been impossible to
define the dissemination rate; these bacteria are fully capable of
replicating in spleens. Also, we observed that the number of
KIM10-PLA CFU retained in the lungs is dramatically
reduced by day 2, with a corresponding rise in the isolation of
KIM10-PLA from spleens. These results suggest that the high
expression of PLAbyY. pestis induces the rapid phagocytosis by
alveolar Ms, resulting in bacterial clearance or dissemination
and that the mutant strains can assist in modeling various
stages of Y. pestis pathogenicity. As shown in Figs. 3 and 5,
KIM10-PLA invades alveolar Ms and CHO-DEC-205 more
effectively than the KIM6, suggesting that the expression of
PLA in KIM10-PLA might be higher than in KIM6.
For the same reason, we speculate that Y. pestis KIM6 bac-
teria can only survive for about 2–3 days after being phagocy-
tosed or if they have initiated the dissemination process. Fig. 7
shows that after a short increase in dissemination on day 2, the
recovery rates of KIM10-PLA fromboth lungs and spleens are
dramatically reduced. The data thus suggest that the dissemi-
nation is initiated after bacteria are phagocytosed. We would
also like to mention that we were unable to demonstrate spleen
dissemination by KIM6 (data not shown) but do show for
KIM6 in this study.We believe that the pgm locusmay help Y.
pestis to survive in the Ms during infection, as shown in a
recent study (55).
The overall dissemination rate is very low (Fig. 7). In whole
spleens, an average of 500 KIM6 CFU was recovered at the
peak of dissemination. Based on the study of Lathem et al. (18),
the number of Y. pestis CO92 could reach 108–109 in spleens
before thesemice succumbed to the infection. It is possible that
the nonvirulent strains are more susceptible to killing in the
host, thus affecting overall dissemination numbers. Alterna-
tively, it is possible that only a small fraction of the inoculum
was able to reach the lungs. Two observations should be recog-
nized here. First, the only difference betweenwild-typeY. pestis
and KIM6 is the lack of the pYV plasmid in the latter, possibly
affecting its ability to disseminate and/or survive. Second,
under the experimental conditions described in this study, we
were unable to isolate bacteria from blood samples of the
infected mice (data not shown). We speculate that the bacteria
transit in the bloodstream at concentrations too low or too
rapidly for detection. It is also possible that the bacteria isolated
from spleens have not entered there via the bloodstreambut via
an as yet unknown mechanism.
We also utilized the Y. pestis strain KIM10-ail, which is
highly attenuated. The deleted components of this strain
include the pgm locus, pPCP1 plasmid, the pYV plasmid
(encoding type III secretion system and other cytotoxic com-
ponents), and the ail gene (40). The reason for selecting this
strain was to reduce the interference of other known virulence
components, which might mask aspects of the pathogen-host
interaction under study. For example, although Y. pestis does
not express invasin, it directly interacts with epithelial cells
such as HeLa cells (52). We have observed that the interaction
of Y. pestiswith epithelial cells might involve the binding of the
Ail protein with cell surface heparan sulfate proteoglycans.5 As
shown in Fig. 5, KIM10-ail or KIM10-ail-PLA has lost
their ability to interact with epithelial cells in the absence of
either SIGN-R1 or DEC-205.
Another issue of concern is why we used such a high concen-
tration (OD  1.5) of Y. pestis CFU as an inoculum. For the
nonvirulent strains of Y. pestis, this large inoculum was
required for us to recover any bacteria disseminating to the
spleen. It is known that Y. pestis is an extremely virulent patho-
gen. Several experiments have indicated that LD50 of Y. pestis
can be as low as 1 (62). However, to dissect the course of the
bacterial infection, the use of attenuated Y. pestis mutants is
more suitable.
In our recent studies (20),4 we have utilized the anti-human
DC-SIGN and anti-mouse SIGN-R1 antibodies to inhibit the
interactions of Y. pestis with human monocyte-derived DCs
and mouse Ms, but neither of these antibodies was effective.
In fact, we must combine both anti-human DC-SIGN and -hu-
man Langerin (CD207) (another host receptor for Y. pestis)5
antibodies to show a moderate reduction in this interaction
(20). As shown in Fig. 6A in this study, interaction of Y. pestis
with alveolar Ms was reduced by half following a single anti-
DEC-205 antibody treatment, indicating that DEC-205 is a
major receptor for Y. pestis and plays a specific role during the
phagocytosis of Y. pestis by alveolar Ms. However, this inhi-
bition by anti-DEC-205 antibody was not complete, indicating
that alveolar Ms likely possess an additional receptor(s) for
Y. pestis.
Both Welkos et al. (63) and Lathem et al. (18) indicated that
PLA might not play a significant role in dissemination if the
strain CO92 was infected via aerosol inhalation to non-human
primates and intranasal route to mice, respectively. CO92, the
most virulent strain, was used in their studies. Therefore, we
suggest that binding of the bacteria to APCs, although actively
blocking endocytosis via the type III secretion system, may
facilitate the transport of viable bacteria to lymph nodes. As
shown in Fig. 7, the KIM10, without expression of PLA, was
still able to be disseminated, although not as efficiently at the
KIM6.
What are the other possible mechanisms for promoting dis-
semination of Y. pestis? This study focused on the interactive
roles between PLA of Y. pestis and DEC-205 of alveolar Ms.
However, it is likely that mouse pulmonary DCs, which express
both DEC-205 and Langerin (CD207) rather than alveolar
Ms, are the cells responsible for migrating between tissues
(64–66). Therefore, we would like to propose another model
for pneumonic plague. After entering the lungs via aspiration,
Y. pestis uses its Ail protein (40, 67) to bind to cell surface hepa-
ran sulfate proteoglycans and invade epithelial layers of bron-
chial tracts in the lungs. Then the Y. pestis encounters the pul-
monary DCs via the SIGN-R1, DEC-205, or Langerin, which
lead to the dissemination.
We have presented evidence in vitro and in vivo showing that
Y. pestismay use the PLA-DEC-205 interaction to promote its
invasion and possible dissemination. However, the fundamen-
tal question still remains as towhether the PLA-DEC-205 inter-
action plays a role in an in vivo infection.
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Themost straightforward approachwould be to test whether
a DEC-205 knock-out mouse model would be resistant to
plague or reduce the dissemination of Y. pestis, an experiment
that we are pursuing. The knock-out mouse model has been
used successfully to identify viral receptors. For example, the
CEACAM1 (CD66a) receptor knock-out mice have an
increased resistance to mouse hepatitis viral infection (68),
because mouse CEACAM1 is a receptor for mouse hepatitis
virus (69). However, there are potential limitations of this
approach for studying bacteria-host cell interactions. Strangely,
there are no credible receptor knock-out models that are more
resistant to bacterial infection. The reason might be simple;
bacterial infections are more multifactorial than viral infec-
tions. Knock-out of one receptormight not be enough to deter-
mine the fate of a bacterial infection, a fact that might contrib-
ute to the failure of CCR5 knock-mice to resist Y. pestis
infection (32, 70), even if CCR5 is a receptor for Y. pestis. Thus
the mouse knock-out model may only provide unequivocal
results if DEC-205 is the only receptor for Y. pestis. Unfortu-
nately, many pathogens do not depend on only one receptor in
their interactions with host cells, as we have indicated in our
published or unpublished data5 that Y. pestis interacts with
human DC-SIGN, human Langerin, mouse SIGN-R1, mouse
Langerin, cell surface heparan sulfate proteoglycan, and of
course mouse DEC-205.
Taken together, this study has demonstrated that DEC-205
functions as a cellular receptor for Y. pestis, with PLA serving as
a ligand. The data presented in this study indicate that interac-
tions between PLA andDEC-205may play a role in the dissem-
ination of Y. pestis.
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